- Home
- » Tags
- » Chromogranin A
Top View
- EGF-Induced Proliferation of Adult Human Pancreatic Duct Cells Is Mediated by the MEK/ERK Cascade
- IHC PANEL MARKERS Lung Cancer
- Role of Synaptophysin, Chromogranin and CD56 in Adenocarcinoma And
- Serum Tumor Markers for Malignancies AHS – G2124
- Immunohistochemical Expression Patterns of Neural and Neuroendocrine Markers, the Neural Growth Factor Receptors and the ‚-Tubulin II and IV Isotypes in Human Thymus
- Metastatic Conventional Prostatic Adenocarcinoma with Diffuse Chromogranin a and Androgen Receptor Positivity M P Roudier, L D True, R L Vessella, C S Higano
- Downloaded from Bioscientifica.Com at 10/01/2021 01:13:42PM Via Free Access
- Primary Neuroendocrine Neoplasms of the Breast: Case Series and Literature Review
- Independent Prognostic Role of Circulating Chromogranin a in Prostate Cancer Patients with Hormone-Refractory Disease
- A Novel Approach to Identification of Diagnostic Markers In
- Comparative Immunohistochemical Staining for Chromogranin a And
- HER-2/Neu Cytoplasmic Staining Is Correlated with Neuroendocrine Differentiation in Breast Carcinoma
- Tumor Markers: an Overview
- Neuropeptide-Processing Enzymes: Applications for Drug Discovery Submitted: April 22 , 2005 ; Accepted: May 30 , 2005 ; Published: October 5, 2005 Lloyd D
- 167 Tumor Markers
- Aberrant Expression of Immunohistochemical Markers in Malignant Melanoma: a Review
- USCAP 2015 Bone and Soft Tissue Evening Specialty Conference Case
- Chromogranin a As a Marker of Neuroendocrine Neoplasia: an Italian Multicenter Study
- Immunohistochemical Expression Patterns of S100, Synapto
- Glycosylated Chromogranin A: Potential Role in the Pathogenesis
- Chromogranin a Restricts Drug Penetration and Limits the Ability of NGR-TNF to Enhance Chemotherapeutic Efficacy
- Chromogranin a Detection in Saliva of Type 2 Diabetes Patients
- Chromogranin a Expression in Neoplastic Cells Affects Tumor Growth and Morphogenesis in Mouse Models1
- Clinical Relevance of Liquid Biopsy in Melanoma and Merkel Cell Carcinoma
- Detection of Prostate Cancer and Predicting Progression: Current and Future Diagnostic Markers
- Terminal Neuroendocrine Differentiation of Human Prostate Carcinoma Cells in Response to Increased Intracellular Cyclic AMP (Hormoe Refraory/Pp6ow/Muwl Tntwa1) Y.-J
- Primary Neuroendocrine Breast Carcinomas Are
- Rapid Progression of Mixed Neuroendocrine Carcinoma‑Acinar Adenocarcinoma of the Prostate: a Case Report
- Response Prediction of 177Lu-PSMA-617 RLT Using PSA, Chromogranin A, and LDH
- Neuroendocrine Carcinoma of the Breast - Diagnostic and Clinical Implications
- Tumor Markers in Lung Cancer
- Transcriptomic Characterization of Fibrolamellar Hepatocellular
- Alpha–Fetoprotein Elevation in NUT Midline Carcinoma: a Case Report
- Elevated Serum Alpha-Fetoprotein in Poorly Differentiated
- Neuroendocrine Carcinoma of Gallbladder: a Case Series and Literature Review Wei Liu†, Weijie Chen†, Jiemin Chen, Tao Hong, Binglu Li, Qiang Qu and Xiaodong He*
- A Comparison of Synaptophysin, Chromogranin, and L-Dopa Decarboxylase As Markers for Neuroendocrine Differentiation in Lung Cancer Cell Lines1
- Modelling Pancreatic Neuroendocrine Cancer: from Bench Side to Clinic
- Chromogranin a Expression in Normal and Malignant Human Tissues
- Aberrant Intermediate Filament and Synaptophysin Expression
- Emerging Roles of Human Prostatic Acid Phosphatase
- Significance of Chromogranin a and Synaptophysin in Medullary Thyroid Carcinomas